| PTO Form 1966 (Rev 9/2002) |
| OMB Control #0651-0050 (Exp. 04/30/2006) |
| Input Field |
Entered |
| SERIAL NUMBER | 76515116 |
| MARK SECTION (no change) | |
| GOODS AND/OR SERVICES SECTION (1st class)(current) | |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION | |
| research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; providing medical and pharmaceutical information services in all media; scientific research services; design for others in the field of DNA-based assays, DNA sequencing protocols, immunoassay and methods for drug discovery; scientific research, namely, development of pharmaceuticals or diagnostic methods; agrochemical product development for others; educational classes and programs in the field of thalidomide and safety issues pertaining to thalidomide, and distribution of written materials therewith; scientific research services | |
| FILING BASIS | Section 1(a) |
| FIRST USE ANYWHERE DATE | 09/29/1998 |
| FIRST USE IN COMMERCE DATE | 09/29/1998 |
| GOODS AND/OR SERVICES SECTION (1st class)(proposed) | |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION | |
| research in the fields of chemicals and pharmaceuticals; product safety testing in the fields of chemicals and pharmaceuticals; research and dev4elopment of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping base don the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; providing medical and pharmaceutical research information; scientific research services; design for others in the field of DNA-based assays, DNA sequencing protocols, immunoassay and methods for drug discovery; scientific research, namely, development of pharmaceuticals or diagnostic methods for others; agrochemical product development for others | |
| FILING BASIS | Section 1(a) |
| FIRST USE ANYWHERE DATE | 12/31/1986 |
| FIRST USE IN COMMERCE DATE | 12/31/1986 |
| GOODS AND/OR SERVICES SECTION (2nd class)(current) | |
| INTERNATIONAL CLASS | 001 |
| DESCRIPTION | |
| biochemical catalysts for use in medical research; biological preparations for medical purposes, namely for use in the research of immunological, inflammatory and neurological disorders; catalysts for use in the manufacture of pharmaceuticals; chemical preparations, namely, chemical reagents for scientific purposes; enzyme preparations for industrial purposes; enzymes for industrial purposes; proteins for industrial and human consumption, namely animal proteins, genetic testing reagents for scientific laboratory use, namely, DNA probes; chemical preparations used to protect crops in the agricultural and horticultural field | |
| FILING BASIS | Section 1(a) |
| FIRST USE ANYWHERE DATE | 06/28/2001 |
| FIRST USE IN COMMERCE DATE | 06/28/2001 |
| GOODS AND/OR SERVICES SECTION (2nd class)(proposed) | |
| INTERNATIONAL CLASS | 001 |
| DESCRIPTION | |
| biochemical catalysts for use in medical research; biological preparations for medical purposes, namely for use in the research of immunological, inflammatory and neurological disorders; catalysts for use in the manufacture of pharmaceuticals; chemical preparations, namely, chemical reagents for scientific purposes; enzyme preparations for industrial purposes; enzymes for industrial purposes; proteins for industrial and human consumption, namely animal proteins, genetic testing reagents for scientific laboratory use, namely, DNA probes; chemical preparations used to protect crops in the agricultural and horticultural field | |
| FILING BASIS | Section 1(a) |
| FIRST USE ANYWHERE DATE | 12/31/1986 |
| FIRST USE IN COMMERCE DATE | 12/31/1986 |
| GOODS AND/OR SERVICES SECTION (3rd class)(current) | |
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION | |
| biological preparations for medical purposes, namely for use in the treatment of immunological, inflammatory and neurological disorders; pharmaceuticals, genomic and biological agents for use in the fields of immunological, inflammatory and neurological disorders for the identification, analysis, prevention, detection, diagnosis, prognosis and treatment; biological preparations for use in medicinal tests, inoculations, and treatment of diseases, namely, immunological, inflammatory and neurological disorders and cancer; culture media, namely, tissue culture media and bacteriogical culture media for medical use; medicinal and biological preparations for pharmaceutical, clinical or medical laboratory use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system | |
| FILING BASIS | Section 1(a) |
| FIRST USE ANYWHERE DATE | 09/29/1998 |
| FIRST USE IN COMMERCE DATE | 09/29/1998 |
| GOODS AND/OR SERVICES SECTION (3rd class)(proposed) | |
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION | |
| biological preparations for medical purposes, namely for use in the treatment of immunological, inflammatory and neurological disorders; pharmaceuticals, genomic and biological agents for use in the fields of immunological, inflammatory and neurological disorders for the identification, analysis, prevention, detection, diagnosis, prognosis and treatment; biological preparations for use in medicinal tests, inoculations, and treatment of diseases, namely, immunological, inflammatory and neurological disorders and cancer; culture media, namely, tissue culture media and bacteriogical culture media for medical use; medicinal and biological preparations for pharmaceutical, clinical or medical laboratory use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system | |
| FILING BASIS | Section 1(a) |
| FIRST USE ANYWHERE DATE | 12/31/1986 |
| FIRST USE IN COMMERCE DATE | 12/31/1986 |
| GOODS AND/OR SERVICES SECTION (4th class)(current) | |
| INTERNATIONAL CLASS | 040 |
| DESCRIPTION | |
| manufacturing pharmaceutical products for others; custom synthesis of DNA to the order and specification of others; custom manufacturing services, namely, manufacturing agrochemicals to the specification of others | |
| FILING BASIS | Section 1(a) |
| FIRST USE ANYWHERE DATE | 09/29/1998 |
| FIRST USE IN COMMERCE DATE | 09/29/1998 |
| GOODS AND/OR SERVICES SECTION (4th class)(proposed) | |
| INTERNATIONAL CLASS | 040 |
| DESCRIPTION | |
| manufacturing pharmaceutical products for others; custom synthesis of DNA to the order and specification of others; custom manufacturing services, namely, manufacturing agrochemicals to the specification of others | |
| FILING BASIS | Section 1(a) |
| FIRST USE ANYWHERE DATE | 12/31/1986 |
| FIRST USE IN COMMERCE DATE | 12/31/1986 |
| GOODS AND/OR SERVICES SECTION (5th class)(class added) | |
| INTERNATIONAL CLASS | 041 |
| DESCRIPTION | |
| educational classes and programs in the field of thalidomide and safety issues pertaining to thalidomide, and distribution of written materials therewith | |
| FILING BASIS | Section 1(a) |
| FIRST USE ANYWHERE DATE | 12/31/1986 |
| FIRST USE IN COMMERCE DATE | 12/31/1986 |
| PAYMENT SECTION | |
| NUMBER OF CLASSES | 1 |
| SUBTOTAL AMOUNT | 335 |
| TOTAL AMOUNT | 335 |
| SIGNATURE SECTION | |
| SIGNATURE | /Camille M. Miller/ |
| SIGNATORY NAME | Camille M. Miller |
| SIGNATORY POSITION | Attorney |
| SIGNATORY DATE | 12/19/2003 |
| SIGNATURE | /Camille M. Miller/ |
| SIGNATORY NAME | Camille M. Miller |
| SIGNATORY POSITION | Attorney |
| SIGNATORY DATE | 12/19/2003 |
| FILING INFORMATION SECTION | |
| SUBMIT DATE | Fri Dec 19 16:15:46 EST 2003 |
| TEAS STAMP | USPTO/OA-XXXXXXXXXXX-2003 1219161546698104-76515116 -200d2ce1eb012b5a8eaf4f8d ec2a337ab53DA225-20031219 161414452464 |
| PTO Form 1966 (Rev 9/2002) |
| OMB Control #0651-0050 (Exp. 04/30/2006) |
| Application serial no. 76515116 is amended as follows: | |
| Classification and Listing of Goods/Services | |
| Applicant hereby amends the following class of goods/services in the application as follows: | |
| Current: Class 042 for research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; providing medical and pharmaceutical information services in all media; scientific research services; design for others in the field of DNA-based assays, DNA sequencing protocols, immunoassay and methods for drug discovery; scientific research, namely, development of pharmaceuticals or diagnostic methods; agrochemical product development for others; educational classes and programs in the field of thalidomide and safety issues pertaining to thalidomide, and distribution of written materials therewith; scientific research services | |
| Original Filing Basis: 1(a). | |
| Proposed: Class 042 for research in the fields of chemicals and pharmaceuticals; product safety testing in the fields of chemicals and pharmaceuticals; research and dev4elopment of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services, namely pharmacogenetic tests, predictive medical tests, personalized medical tests, gene sequencing-based tests and genotyping base don the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; providing medical and pharmaceutical research information; scientific research services; design for others in the field of DNA-based assays, DNA sequencing protocols, immunoassay and methods for drug discovery; scientific research, namely, development of pharmaceuticals or diagnostic methods for others; agrochemical product development for others | |
| Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, or the applicant's predecessor in interest used the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 12/31/1986 and first used in commerce at least as early as 12/31/1986, and is now in use in such commerce. | |
| Applicant hereby amends the following class of goods/services in the application as follows: | |
| Current: Class 001 for biochemical catalysts for use in medical research; biological preparations for medical purposes, namely for use in the research of immunological, inflammatory and neurological disorders; catalysts for use in the manufacture of pharmaceuticals; chemical preparations, namely, chemical reagents for scientific purposes; enzyme preparations for industrial purposes; enzymes for industrial purposes; proteins for industrial and human consumption, namely animal proteins, genetic testing reagents for scientific laboratory use, namely, DNA probes; chemical preparations used to protect crops in the agricultural and horticultural field | |
| Original Filing Basis: 1(a). | |
| Proposed: Class 001 for biochemical catalysts for use in medical research; biological preparations for medical purposes, namely for use in the research of immunological, inflammatory and neurological disorders; catalysts for use in the manufacture of pharmaceuticals; chemical preparations, namely, chemical reagents for scientific purposes; enzyme preparations for industrial purposes; enzymes for industrial purposes; proteins for industrial and human consumption, namely animal proteins, genetic testing reagents for scientific laboratory use, namely, DNA probes; chemical preparations used to protect crops in the agricultural and horticultural field | |
| Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, or the applicant's predecessor in interest used the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 12/31/1986 and first used in commerce at least as early as 12/31/1986, and is now in use in such commerce. | |
| Applicant hereby amends the following class of goods/services in the application as follows: | |
| Current: Class 005 for biological preparations for medical purposes, namely for use in the treatment of immunological, inflammatory and neurological disorders; pharmaceuticals, genomic and biological agents for use in the fields of immunological, inflammatory and neurological disorders for the identification, analysis, prevention, detection, diagnosis, prognosis and treatment; biological preparations for use in medicinal tests, inoculations, and treatment of diseases, namely, immunological, inflammatory and neurological disorders and cancer; culture media, namely, tissue culture media and bacteriogical culture media for medical use; medicinal and biological preparations for pharmaceutical, clinical or medical laboratory use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system | |
| Original Filing Basis: 1(a). | |
| Proposed: Class 005 for biological preparations for medical purposes, namely for use in the treatment of immunological, inflammatory and neurological disorders; pharmaceuticals, genomic and biological agents for use in the fields of immunological, inflammatory and neurological disorders for the identification, analysis, prevention, detection, diagnosis, prognosis and treatment; biological preparations for use in medicinal tests, inoculations, and treatment of diseases, namely, immunological, inflammatory and neurological disorders and cancer; culture media, namely, tissue culture media and bacteriogical culture media for medical use; medicinal and biological preparations for pharmaceutical, clinical or medical laboratory use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system | |
| Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, or the applicant's predecessor in interest used the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 12/31/1986 and first used in commerce at least as early as 12/31/1986, and is now in use in such commerce. | |
| Applicant hereby amends the following class of goods/services in the application as follows: | |
| Current: Class 040 for manufacturing pharmaceutical products for others; custom synthesis of DNA to the order and specification of others; custom manufacturing services, namely, manufacturing agrochemicals to the specification of others | |
| Original Filing Basis: 1(a). | |
| Proposed: Class 040 for manufacturing pharmaceutical products for others; custom synthesis of DNA to the order and specification of others; custom manufacturing services, namely, manufacturing agrochemicals to the specification of others | |
| Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, or the applicant's predecessor in interest used the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 12/31/1986 and first used in commerce at least as early as 12/31/1986, and is now in use in such commerce. | |
| Applicant hereby adds the following class of goods/services to the application: |
|
| New: Class 041 for educational classes and programs in the field of thalidomide and safety issues pertaining to thalidomide, and distribution of written materials therewith |
|
| Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, or the applicant's predecessor in interest used the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used on 12/31/1986 and first used in commerce on 12/31/1986, and is now in use in such commerce. | |
| Fees | |
| Additional fee(s) in the amount of $335 is being submitted. | |
| Declaration Signature |
|
| The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements may jeopardize the validity of the application or any resulting registration, declares that he/she is properly authorized to execute this amendment/response on behalf of the applicant; he/she believes the applicant to be the owner of the trademark/service mark sought to be registered, and that the mark is in use in commerce, and was in use in commerce on the application filing date, on or in connection with the goods and/or services listed in the application; or, if the application is being filed under 15 U.S.C. Section 1051(b), 1126(d) or 1126(e), he/she believes applicant to be entitled to use such mark in commerce, and that the applicant has a bona fide intention, and had a bona fide intention on the application filing date, to use the mark in commerce on or in connection with the goods and/or services listed in the application; to the best of his/her knowledge and belief no other person, firm, corporation, or association has the right to use the mark in commerce, either in the identical form thereof or in such near resemblance thereto as to be likely, when used on or in connection with the goods and/or services of such other person, to cause confusion, or to cause mistake, or to deceive; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true as set forth within the original application and/or the submitted amendment/response. | |
| Signature: /Camille M. Miller/ Date: 12/19/2003 | |
| Signatory's Name: Camille M. Miller | |
| Signatory's Position: Attorney | |
| Response Signature | |
| Signature: /Camille M. Miller/ Date: 12/19/2003 | |
| Signatory's Name: Camille M. Miller | |
| Signatory's Position: Attorney | |
| RAM Sale Number: 225 | |
| RAM Accounting Date: 12/22/2003 | |
| Serial Number: 76515116 | |
| Internet Transmission Date: Fri Dec 19 16:15:46 EST 2003 | |
| TEAS Stamp: USPTO/OA-XXXXXXXXXXX-2003121916154669810 4-76515116-200d2ce1eb012b5a8eaf4f8dec2a3 37ab53DA225-20031219161414452464 |